Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $.01 par value
-
Shares outstanding
-
4.41M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
751K
-
Shares change
-
-193K
-
Total reported value, excl. options
-
$3.89M
-
Value change
-
-$1M
-
Number of buys
-
9
-
Number of sells
-
-1
-
Price
-
$5.18
Significant Holders of INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value (IDXG) as of Q1 2020
11 filings reported holding IDXG - INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value as of Q1 2020.
INTERPACE BIOSCIENCES, INC. - Common Stock, $.01 par value (IDXG) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 751K shares
of 4.41M outstanding shares and own 17.03% of the company stock.
Largest 10 shareholders include PERKINS CAPITAL MANAGEMENT INC (224K shares), Stonepine Capital Management, LLC (178K shares), VANGUARD GROUP INC (119K shares), BlackRock Inc. (117K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (65.4K shares), GEODE CAPITAL MANAGEMENT, LLC (32.5K shares), DIMENSIONAL FUND ADVISORS LP (11K shares), Allworth Financial LP (1.43K shares), UBS Group AG (1.39K shares), and Federation des caisses Desjardins du Quebec (1K shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.